Posts by rw-admin
As Am Law 50 Firms Raise Billing Rates by Double Digits, Partner Profits Soar
More Am Law 200 firms are battling rising costs this year than they were in the first half of 2024. But according to recent data from the Wells Fargo Legal Specialty Group, their revenues are soaring by double digits, mostly because billing rates are increasing more quickly than they were previously.
Read MoreHighest Number of Law School Applicants Since 2011, Most Diverse Applicants in History
For the 2024–2025 application cycle, the Law School Admission Council received over half a million applications, the most since 2011. The number of applications exceeded the COVID-19 epidemic boom by over 8%.
Read MoreThe Biglaw Firm Bucking The Return To Office Trend
The Link, Husch Blackwell’s entirely virtual office, is operational. We worked it out. Those who were extremely successful and then benefited from it, and now their corporations and firms are saying, “Well, we don’t care. We want you to go back in the office,” J.Y. Miller, managing partner of Husch Blackwell’s The Link, told Law.com…
Read MoreSkadden Advises Intel On President Deal, Because What Are A Few Obvious Conflicts Among Friends?
Intel recently consented to transfer ownership of about 10% of the company to the federal government. According to reports, the federal government is required to vote with the board on the common stock agreement unless the board is voting to sabotage the agreement. The agreement fulfills the CHIPS Act, which authorizes $280 billion in subsidies…
Read MoreKey Trends Shaping Life Sciences IP Licensing
The life sciences sector is still changing quickly due to global market dynamics, changing economic situations, and technology breakthroughs. A number of important trends that could have major legal and commercial ramifications are emerging as businesses negotiate this complicated environment.
Read MoreGibson Dunn Advises Royalty Pharma on Acquisition of Royalty Interest in Amgen’s Imdelltra
In an acquisition of a royalty stake in Amgen’s Imdelltra, a first-in-class DLL3 targeting bispecific T-cell engager (BiTE), from BeOne Medicines for a maximum of $950 million, Gibson Dunn is representing Royalty Pharma plc.
Read MoreBaker McKenzie Acts for MicroBit Capital Management on Launch of Spot Bitcoin ETF and Ether ETF in Hong Kong
The MicroBit Bitcoin Spot ETF (Stock Code: 3430.HK / 9430.HK) and the MicroBit Ether Spot ETF (Stock Code: 3425.HK / 9425.HK) were successfully listed on the Hong Kong Stock Exchange on August 21, 2025, with Baker McKenzie’s assistance. MicroBit Capital Management Limited (“MicroBit”) is a leading investment manager based in Hong Kong that specializes in…
Read MoreDentons Rodyk Set to Welcome Leading Family Law Practitioner Wong Kai Yun
Dentons Rodyk is happy to announce that Wong Kai Yun, a renowned family law expert, will become a Senior Partner in the firm’s Family & Matrimonial practice on October 16, 2025.
Read MoreAkerman Facilitates Major Milestone in Brickell City Centre Expansion with $45M Sale
The construction property at 9 SE 6th Street in Miami, Florida, a crucial piece of land within the Brickell City Centre Special Area Plan (SAP), was sold for $45 million by Akerman on behalf of Swire Properties. The deal brings a globally recognized hospitality brand to the Brickell skyline and represents a turning point in…
Read MoreNorton Rose Fulbright advises Standard Chartered Bank, HSBC and SMBC on a syndicated murabaha financing to Qatar Islamic Bank
Standard Chartered Bank (SCB), HSBC Bank Middle East Ltd (HSBC), and SMBC Bank International (SMBC) are the mandated lead arrangers, bookrunners, and global coordinators. Norton Rose Fulbright has provided advice to a syndicate of participants regarding the closure of Qatar Islamic Bank’s (QIB) three-year dual-tranche term Murabaha Financing Facility.
Read More